Deutsche Bank
FBLG icon

Deutsche Bank’s FibroBiologics FBLG Stock Holding History

Deutsche Bank’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$4 – 3742
2025
Q4 		$4 Hold
1
– – ﹤0.01% 3616
2025
Q3 		$10 Hold
1
– – ﹤0.01% 3597
2025
Q2 		$11 Sell
1
-129
-99% -$2.33K ﹤0.01% 3598
2025
Q1 		$2.34K Buy
130
+54
+71% +$1.54K ﹤0.01% 3548
2024
Q4 		$3.03K Buy
76
+42
+124% +$2.25K ﹤0.01% 3558
2024
Q3 		$2.1K Hold
34
– – ﹤0.01% 3570
2024
Q2 		$3.39K Buy
+34
New +$6.49K ﹤0.01% 3511

Other funds holding FBLG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.25B AUM 14.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $970M AUM 19.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

Deutsche Bank's FBLG Position: Q1 2026 in Review

Deutsche Bank sold out of FibroBiologics (FBLG) in Q1 2026, closing a stake of 1 share — an estimated $4 sold.

Deutsche Bank first reported a position in FBLG in Q2 2024 and held it in 7 quarters. The position peaked at $3.39K in Q2 2024. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

  • Deutsche Bank reported no remaining FibroBiologics position as of Q1 2026 after selling out during the quarter.
  • Deutsche Bank sold 1 FibroBiologics share in Q1 2026, an estimated $4.
  • Deutsche Bank first reported a position in FibroBiologics in Q2 2024 and held it in 7 quarters.
  • Deutsche Bank's FibroBiologics position peaked at $3.39K in Q2 2024.
  • 17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.